KRAS and non-small cell lung carcinoma: It can be used to select patients for cetuximab (Erbitux®) treatment for rtPCR analysis to detect the G12C mutation in the human KRAS gene in DNA extracted from the FFPE lung tissue of patients with NSCLC.